Research Report

Oxford Expression Technologies: making baculovirus expression accessible for protein production and vaccine development

Abstract

Oxford Expression Technologies (OET) is a spin out company launched jointly by Oxford Brookes University (Brookes) and the Natural Environment Research Council (NERC) to exploit Intellectual Property (IP) in the field of protein expression using novel insect virus vectors. OET generates revenue through sale of kits, services & licences to a range of global customers including academia, research institutes, pharmaceutical and biotechnology companies. OET provides employment, invests in in-house Research and Development including funding collaborative PhD students, and generates royalty income streams for Brookes and NERC. Customers are able to produce multiple recombinant proteins to higher yields and quality than was otherwise possible and a number of companies are using the developments for the commercial production of vaccines and other uses.

Attached files

Authors

King, L (Oxford Brookes University)

Oxford Brookes departments

Faculty of Health and Life Sciences\Department of Biological and Medical Sciences

Dates

Year of publication: 2013
Date of RADAR deposit: 2014-12-18

---

© Oxford Brookes University
Published by Oxford Brookes University

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License